
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8713072
[patent_doc_number] => 08399211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 12/586459
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 12032
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12586459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/586459 | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use | Sep 21, 2009 | Issued |
Array
(
[id] => 8199890
[patent_doc_number] => 08187597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Combination therapy for the treatment of ocular neovascular disorders'
[patent_app_type] => utility
[patent_app_number] => 12/564863
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 24
[patent_no_of_words] => 31651
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/187/08187597.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564863 | Combination therapy for the treatment of ocular neovascular disorders | Sep 21, 2009 | Issued |
Array
(
[id] => 6301978
[patent_doc_number] => 20100068137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Dock-and-Lock (DNL) Vaccines for Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/544476
[patent_app_country] => US
[patent_app_date] => 2009-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25747
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068137.pdf
[firstpage_image] =>[orig_patent_app_number] => 12544476
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/544476 | Dock-and-lock (DNL) vaccines for cancer therapy | Aug 19, 2009 | Issued |
Array
(
[id] => 7800662
[patent_doc_number] => 08128932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Anti-VEGFR monoclonal antibody, method of making and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/542239
[patent_app_country] => US
[patent_app_date] => 2009-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11057
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/128/08128932.pdf
[firstpage_image] =>[orig_patent_app_number] => 12542239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/542239 | Anti-VEGFR monoclonal antibody, method of making and uses thereof | Aug 16, 2009 | Issued |
Array
(
[id] => 6468197
[patent_doc_number] => 20100040675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROMOTING OR INHIBITING ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/538952
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25946
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12538952
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/538952 | Compositions and methods for promoting or inhibiting angiogenesis | Aug 10, 2009 | Issued |
Array
(
[id] => 11581799
[patent_doc_number] => 09636420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Polypeptide complex comprising non-peptidyl polymer having three functional ends'
[patent_app_type] => utility
[patent_app_number] => 13/055406
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9208
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055406
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055406 | Polypeptide complex comprising non-peptidyl polymer having three functional ends | Jul 22, 2009 | Issued |
Array
(
[id] => 6528982
[patent_doc_number] => 20100015161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/505156
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14903
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015161.pdf
[firstpage_image] =>[orig_patent_app_number] => 12505156
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505156 | Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of Cancer | Jul 16, 2009 | Abandoned |
Array
(
[id] => 6625714
[patent_doc_number] => 20100034837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/502433
[patent_app_country] => US
[patent_app_date] => 2009-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 47080
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20100034837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502433 | Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds | Jul 13, 2009 | Issued |
Array
(
[id] => 6183969
[patent_doc_number] => 20110123551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'HVEM/BTLA, HVEM/CD 160 AND HVEM/GD CIS COMPLEXES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/003191
[patent_app_country] => US
[patent_app_date] => 2009-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 25520
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123551.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003191
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003191 | HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use | Jul 7, 2009 | Issued |
Array
(
[id] => 6187863
[patent_doc_number] => 20110171242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/498256
[patent_app_country] => US
[patent_app_date] => 2009-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 37647
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12498256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/498256 | LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE | Jul 5, 2009 | Abandoned |
Array
(
[id] => 6096405
[patent_doc_number] => 20110003382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'USE OF CORTICOSTERONE FOR INCREASING EGG ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/496223
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6900
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003382.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496223
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496223 | USE OF CORTICOSTERONE FOR INCREASING EGG ANTIBODY | Jun 30, 2009 | Abandoned |
Array
(
[id] => 7731561
[patent_doc_number] => 20120014958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF'
[patent_app_type] => utility
[patent_app_number] => 13/000423
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29018
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20120014958.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000423
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000423 | Stable and soluble antibodies inhibiting VEGF | Jun 24, 2009 | Issued |
Array
(
[id] => 5473048
[patent_doc_number] => 20090246214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'FUSION PROTEINS CONTAINING RECOMBINANT CYTOTOXIC RNASES'
[patent_app_type] => utility
[patent_app_number] => 12/479250
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12136
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12479250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/479250 | Fusion proteins containing recombinant cytotoxic RNAses | Jun 4, 2009 | Issued |
Array
(
[id] => 6080100
[patent_doc_number] => 20110142839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'TREATMENT OF PULMONARY EDEMA'
[patent_app_type] => utility
[patent_app_number] => 12/995389
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18087
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995389 | TREATMENT OF PULMONARY EDEMA | May 28, 2009 | Abandoned |
Array
(
[id] => 8146289
[patent_doc_number] => 08163291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses'
[patent_app_type] => utility
[patent_app_number] => 12/468589
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 28
[patent_no_of_words] => 22375
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163291.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468589 | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses | May 18, 2009 | Issued |
Array
(
[id] => 5551766
[patent_doc_number] => 20090285752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/467645
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13307
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467645
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467645 | IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS | May 17, 2009 | Abandoned |
Array
(
[id] => 7711906
[patent_doc_number] => 08093018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 12/467853
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 10952
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/093/08093018.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467853 | Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same | May 17, 2009 | Issued |
Array
(
[id] => 9936897
[patent_doc_number] => 08986702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Antibodies and processes for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 12/467957
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 49495
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12467957
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467957 | Antibodies and processes for preparing the same | May 17, 2009 | Issued |
Array
(
[id] => 6314142
[patent_doc_number] => 20100111942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/465051
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 31414
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111942.pdf
[firstpage_image] =>[orig_patent_app_number] => 12465051
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/465051 | Combination therapy for the treatment of ocular neovascular disorders | May 12, 2009 | Issued |
Array
(
[id] => 5515415
[patent_doc_number] => 20090215722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Inhibition of Antigen Presentation with Poorly Catabolized Polymers'
[patent_app_type] => utility
[patent_app_number] => 12/463315
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5211
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215722.pdf
[firstpage_image] =>[orig_patent_app_number] => 12463315
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/463315 | Inhibition of antigen presentation with poorly catabolized polymers | May 7, 2009 | Issued |